Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemiaHIRAKI, Akio; UEOKA, Hiroshi; BESSHO, Akihiro et al.Cancer. 2002, Vol 95, Num 8, pp 1706-1713, issn 0008-543X, 8 p.Article

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancerTAKIGAWA, Nagio; SEGAWA, Yoshihiko; UEOKA, Hiroshi et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 4, pp 272-278, issn 0344-5704Article

STAT3 expression in activating EGFR-driven adenocarcinoma of the lungTAKATA, Saburo; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2012, Vol 75, Num 1, pp 24-29, issn 0169-5002, 6 p.Article

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancerUMEMURA, Shigeki; SEGAWA, Yoshihiko; UEOKA, Hiroshi et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 8, pp 519-524, issn 0171-5216, 6 p.Article

Hypercalcemia-leukocytosis syndrome associated with lung cancerHIRAKI, Akio; UEOKA, Hiroshi; HARADA, Mine et al.Lung cancer. 2004, Vol 43, Num 3, pp 301-307, issn 0169-5002, 7 p.Article

Phase i study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancerNOGAMI, Naoyuki; HARITA, Shingo; UEOKA, Hiroshi et al.Lung cancer. 2004, Vol 45, Num 1, pp 85-91, issn 0169-5002, 7 p.Article

Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examinationSAWADA, Shigeki; KOMORI, Eisaku; NOGAMI, Naoyuki et al.Lung cancer. 2009, Vol 65, Num 2, pp 176-179, issn 0169-5002, 4 p.Article

Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical conditionSAWADA, Shigeki; KOMORI, Eisaku; NOGAMI, Naoyuki et al.Chest. 2005, Vol 128, Num 3, pp 1557-1563, issn 0012-3692, 7 p.Article

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsTAKIGAWA, Nagio; SEGAWA, Yoshihiko; GEMBA, Kenichi et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 3, pp 230-236, issn 0344-5704, 7 p.Article

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancerSEGAWA, Yoshihiko; UEOKA, Hiroshi; HIRAKI, Shunkichi et al.Lung cancer. 2003, Vol 41, Num 1, pp 13-20, issn 0169-5002, 8 p.Article

Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer : Radiation-induced lung toxicityTAKIGAWA, Nagio; SEGAWA, Yoshihiko; SAEKI, Toshiaki et al.International journal of radiation oncology, biology, physics. 2000, Vol 48, Num 3, pp 751-755, issn 0360-3016Article

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: OLCSG 0007SEGAWA, Yoshihiko; KIURA, Katsuyuki; DEOKA, Hiroshi et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3299-3306, issn 0732-183X, 8 p.Article

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancerCHIKAMORI, Kenichi; KISHINO, Daizo; UEOKA, Hiroshi et al.Lung cancer. 2009, Vol 65, Num 1, pp 74-79, issn 0169-5002, 6 p.Article

Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implicationsSEGAWA, Yoshihiko; TAKATA, Saburo; NISHIMURA, Rieko et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 8, pp 1055-1059, issn 0171-5216, 5 p.Article

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancerSHIBAYAMA, Takuo; HOTTA, Katsuyuki; KUYAMA, Shoichi et al.Lung cancer. 2006, Vol 53, Num 2, pp 189-195, issn 0169-5002, 7 p.Article

Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancerSEGAWA, Yoshihiko; HOTTA, Katsuyuki; UMEMURA, Shigeki et al.Cancer. 2006, Vol 107, Num 8, pp 1866-1872, issn 0008-543X, 7 p.Article

Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasiaTAKIGAWA, Nagio; IDA, Mikiko; SEGAWA, Yoshihiko et al.Anticancer research. 2003, Vol 23, Num 6D, pp 5069-5073, issn 0250-7005, 5 p.Article

Successful treatment of limited disease-small cell lung cancer with multimodality treatment consisting of concurrent chemoradiotherapy, high-dose chemotherapy with autologous peripheral blood stem cell transplantation and surgical resectionHOTTA, Katsuyuki; UEOKA, Hiroshi; TANIMOTO, Mitsune et al.Internal medicine (Tokyo. 1992). 2003, Vol 42, Num 12, pp 1223-1227, issn 0918-2918, 5 p.Article

Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung CancerTAKAHASHI, Toshiaki; YAMAMOTO, Nobuyuki; SEGAWA, Yoshihiko et al.Anticancer research. 2010, Vol 30, Num 2, pp 557-563, issn 0250-7005, 7 p.Article

Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinomaSEKI, Nobuhiko; TAKASU, Tasaburo; SAWADA, Shigeki et al.Lung cancer. 2010, Vol 70, Num 3, pp 329-334, issn 0169-5002, 6 p.Article

A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer : a phase I/II studyTABATA, Masahiro; KOZUKI, Toshiyuki; SEGAWA, Yoshihiko et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 1, pp 53-59, issn 0344-5704, 7 p.Article

Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lungKOZUKI, Toshiyuki; HISAMOTO, Akiko; TANIMOTO, Mitsune et al.Lung cancer. 2007, Vol 58, Num 1, pp 30-35, issn 0169-5002, 6 p.Article

Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell lineCHIKAMORI, Masakazu; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Anticancer research. 2004, Vol 24, Num 6, pp 3911-3916, issn 0250-7005, 6 p.Article

Fractionated administration of irinotecan and cisplatin for treatment of extensive - disease small - cell lung cancer: A phase II studyTAKIGAWA, Nagio; FUJIWARA, Keiichi; TANIMOTO, Mitsune et al.Anticancer research. 2003, Vol 23, Num 1B, pp 557-560, issn 0250-7005, 4 p.Article

Focal ground-glass opacity detected by low-dose helical CTNAKATA, Masao; SAEKI, Hideyuki; TAKATA, Ichiro et al.Chest. 2002, Vol 121, Num 5, pp 1464-1467, issn 0012-3692Conference Paper